In a prospective, observational study, researchers did not identify any new safety signals with long-term use of vedolizumab for patients with inflammatory bowel disease (IBD).
This prospective, observational, multicenter cohort study included…
In a prospective, observational study, researchers did not identify any new safety signals with long-term use of vedolizumab for patients with inflammatory bowel disease (IBD).
This prospective, observational, multicenter cohort study included…